Literature DB >> 24038431

Using computational strategies to predict potential drugs for nasopharyngeal carcinoma.

Ming-Ying Lan1, Wu-Lung R Yang, Kuan-Ting Lin, Jin-Ching Lin, Yih-Jyh Shann, Ching-Yin Ho, Chi-Ying F Huang.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a unique cancer. Refinement of current therapy by discovering potential drugs may be approached by several computational strategies.
METHODS: We collected NPC genes from published microarray data and the literature. The NPC disease network was constructed via a protein-protein interaction (PPI) network. The Connectivity Map (CMap) was used to predict potential chemicals, and support vector machines (SVMs) were further utilized to classify the effectiveness of tested drugs against NPC using their gene expression from CMap.
RESULTS: A highly interconnected network was obtained. Several chemically sensitive genes were identified and 87 drugs were predicted with the potential for treating NPC by SVM, in which nearly half of them have anticancer effects according to the literature. The 2 top-ranked drugs, thioridazine and vorinostat, were demonstrated to be effective in inhibiting NPC cells.
CONCLUSION: This in silico approach provides a promising strategy for screening potential therapeutic drugs for NPC treatment.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  anticancer; connectivity map; nasopharyngeal carcinoma; protein-protein interactions; support vector machines

Mesh:

Substances:

Year:  2013        PMID: 24038431     DOI: 10.1002/hed.23464

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma.

Authors:  Yen-Bin Hsu; Ming-Chin Lan; Yu-Lun Kuo; Chi-Ying F Huang; Ming-Ying Lan
Journal:  Invest New Drugs       Date:  2019-04-16       Impact factor: 3.850

Review 2.  Big Data in Head and Neck Cancer.

Authors:  Carlo Resteghini; Annalisa Trama; Elio Borgonovi; Hykel Hosni; Giovanni Corrao; Ester Orlandi; Giuseppina Calareso; Loris De Cecco; Cesare Piazza; Luca Mainardi; Lisa Licitra
Journal:  Curr Treat Options Oncol       Date:  2018-10-25

Review 3.  Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

Authors:  J Javier Hernandez; Michael Pryszlak; Lindsay Smith; Connor Yanchus; Naheed Kurji; Vijay M Shahani; Steven V Molinski
Journal:  Front Oncol       Date:  2017-11-14       Impact factor: 6.244

4.  Podoplanin, a Potential Therapeutic Target for Nasopharyngeal Carcinoma.

Authors:  Yen-Bin Hsu; Chi-Ying F Huang; Kuan-Ting Lin; Yu-Lun Kuo; Ming-Chin Lan; Ming-Ying Lan
Journal:  Biomed Res Int       Date:  2019-06-20       Impact factor: 3.411

5.  Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells.

Authors:  Ming-Ying Lan; Yen-Bin Hsu; Ming-Chin Lan; Jyh-Ping Chen; Yu-Jen Lu
Journal:  Int J Nanomedicine       Date:  2020-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.